2019-2020年意大利普通人群麻疹抗体血清流行病学调查
该多中心研究采用ELISA法检测2019-2020年意大利13个大区6-64岁健康人群的3746份血清样本,麻疹IgG抗体总血清阳性率为91.2%(男性90.6%,女性91.7%),6-9岁组为94.2%,40-64岁组为97.6%,南部(93.2%)显著高于中北部(88.9%)。作者认为需继续努力实施和维持高麻疹疫苗接种覆盖率以避免未来疫情暴发风险。
要点
- 麻疹IgG总血清阳性率为91.2%,男性90.6%,女性91.7%。
- 6-9岁组血清阳性率94.2%,40-64岁组97.6%,显著高于其他年龄组(p<0.05)。
- 南部血清阳性率93.2%显著高于中北部88.9%。
核心结论
- 研究结果显示总血清阳性率较既往调查有所升高,但仍需努力实施和维持高麻疹疫苗接种覆盖率以避免未来疫情暴发风险。
研究设计与样本
- 多中心研究,采用ELISA法(Enzygnost Anti-VZV/IgG,Siemens Healthcare Diagnostic Products GmbH,德国)检测2019-2020年采集自意大利13个大区6-64岁健康人群的3746份血清样本,按年龄、性别和地理区域估计抗麻疹IgG抗体流行率。
主要发现
- 抗麻疹IgG总血清阳性率为91.2%(男性90.6%,女性91.7%)。
- 研究人群中极端年龄组血清阳性率显著更高(p<0.05):6-9岁组94.2%,40-64岁组97.6%。
- 20-39岁和40-64岁受试者抗体滴度显著更高,提示其针对麻疹的保护主要来自自然感染。
- 南部血清阳性率(93.2%)显著高于中北部意大利(88.9%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In Italy, the measles elimination target has not yet been reached despite a significant reduction in cases. A multicenter study was conducted to estimate the prevalence of anti-measles (MV) IgG antibodies in the Italian population by age, sex and geographical area. To determine the level of MV-specific antibodies in sera, the immunoenzymatic assay ELISA was used (Enzygnost Anti-VZV/IgG, Siemens Healthcare Diagnostic Products GmbH, Germany). Overall, 3746 serum samples collected in the years 2019-20 from healthy subjects aged 6-64 years residing in 13 Italian regions. The overall seroprevalence of anti-MV IgG was 91.2 % (90.6 % male, 91.7 % female). Significantly higher seroprevalence values (p < 0.05) were recorded for the extreme age groups of the study population (6-9 years: 94.2 %; 40-64 years: 97.6 %). Subjects 20-39 and 40-64 years old had significantly higher antibody titers suggesting a protection against measles mainly derived from natural infection. Seroprevalence was significantly higher in the South (93.2 %) than in the Northern-Central Italy (88.9 %). The results indicate an increase in the overall seroprevalence data compared to previous investigations. However, further efforts must be made to implement and maintain high measles vaccination coverage to avoid the risk of future epidemic outbreaks.
引用
- Grassi T, Bagordo F, Rota MC, et al. Seroprevalence of measles antibodies in the Italian general population in 2019-2020. Vaccine. 2024. PMID: 38821819. doi:10.1016/j.vaccine.2024.05.060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。